A Sign of the Times: NanoString Signature Series (APAC)
Principal Scientist and Associate Director, Molecular Assay Services, Pharma
Dr. Lakshmi Chandramohan is a principal scientist/Associate Director for Molecular Assay Services at NeoGenomics. She has extensive experience in molecular diagnostic test development in the area of infectious diseases and oncology for biomarker discovery and patient care. Dr. Chandramohan serves as an expert panel member on the Clinical Laboratory Standards Institute (CLSI) Preexamination processes panel and has authored several book chapters and articles in peer-reviewed journals. She received her PhD in Biochemistry and Microbiology from University of Nebraska Medical Center, Omaha. Dr. Chandramohan is board certified by American Board of Medical Microbiology and holds New York State Department of Health certificate of qualification (COQ) in Oncology – molecular and cellular tumor markers.
Carlee is a Lead Scientist I at the Covance CDx laboratory in RTP, NC with a background in histology, anatomical pathology and bioinformatics. Her current role is the development of IHC or multiplex immuno florescence assays, or computational pathology algorithms, for clients interested in a complementary or companion diagnostic testing assay for their immuo-oncology pharmaceutical drug development pipeline.